{"log_id": 450030569771721931, "direction": 0, "words_result_num": 45, "words_result": [{"probability": {"variance": 0.007353, "average": 0.958792, "min": 0.647766}, "location": {"width": 1148, "top": 219, "height": 50, "left": 196}, "words": "次)进行肝功能检查。对血清氨酶升高的患者,应及时复查肝功能,并增加检查频率。如"}, {"probability": {"variance": 0.015383, "average": 0.961823, "min": 0.376061}, "location": {"width": 1080, "top": 262, "height": 50, "left": 194}, "words": "果转氨酶水平表现为上升趋势,尤其是上升到正常上限的3倍并续不降时,应停药"}, {"probability": {"variance": 0.017259, "average": 0.933432, "min": 0.521499}, "location": {"width": 1089, "top": 306, "height": 45, "left": 251}, "words": "对饮用大量泪精和/或有既往肝脏病史的患者,应慎用该药。华伐他汀禁用于活动生肝"}, {"probability": {"variance": 0.0002, "average": 0.992504, "min": 0.940151}, "location": {"width": 500, "top": 356, "height": 36, "left": 194}, "words": "脏疾病或原不明的转氨酶升高的患者"}, {"probability": {"variance": 7.7e-05, "average": 0.995131, "min": 0.953653}, "location": {"width": 1089, "top": 390, "height": 47, "left": 253}, "words": "与其它降脂药一样,辛伐他汀治疗后有血清转氨酶中度(低于正常上限的3倍)升高的"}, {"probability": {"variance": 0.001435, "average": 0.9857, "min": 0.801991}, "location": {"width": 1153, "top": 433, "height": 45, "left": 194}, "words": "报道。这些变化在辛伐他汀治疗开始后很快出现,但往往是一过性,不伴有任何症状,不需"}, {"probability": {"variance": 3.3e-05, "average": 0.996822, "min": 0.985322}, "location": {"width": 148, "top": 486, "height": 34, "left": 194}, "words": "要中断治疗"}, {"probability": {"variance": 0.001431, "average": 0.980775, "min": 0.896299}, "location": {"width": 155, "top": 527, "height": 34, "left": 248}, "words": "3.眼科检查"}, {"probability": {"variance": 0.026207, "average": 0.92938, "min": 0.351675}, "location": {"width": 1098, "top": 559, "height": 50, "left": 248}, "words": "即使在没有任何药物治疗时,随着年龄增长晶状体混浊的发病家会增加。长期临床研"}, {"probability": {"variance": 0.023739, "average": 0.907057, "min": 0.457175}, "location": {"width": 756, "top": 607, "height": 41, "left": 194}, "words": "究资料显示:辛位他汀对人的晶状体无不良影响。银器"}, {"probability": {"variance": 0.004432, "average": 0.956456, "min": 0.788287}, "location": {"width": 237, "top": 655, "height": 34, "left": 253}, "words": "4:高甘油三酯血症"}, {"probability": {"variance": 0.006389, "average": 0.974475, "min": 0.530586}, "location": {"width": 1094, "top": 685, "height": 50, "left": 253}, "words": "辛伐他汀仅有中等程度降低甘油三酯的作用,不适合治疗以甘油三酯升高为主的异常情"}, {"probability": {"variance": 0.001598, "average": 0.965669, "min": 0.868446}, "location": {"width": 370, "top": 737, "height": 36, "left": 196}, "words": "况(如I、Ⅳ及V型高脂血症"}, {"probability": {"variance": 0.001132, "average": 0.978361, "min": 0.864937}, "location": {"width": 632, "top": 776, "height": 36, "left": 253}, "words": "5.大量饮酒和/或有肝脏病史的患者,应慎用本品"}, {"probability": {"variance": 0.026293, "average": 0.945219, "min": 0.410356}, "location": {"width": 344, "top": 819, "height": 36, "left": 203}, "words": "【孕妇及哺乳期女用药】"}, {"probability": {"variance": 0.012593, "average": 0.96222, "min": 0.383347}, "location": {"width": 1094, "top": 854, "height": 47, "left": 255}, "words": "尚无孕应用辛伐他汀的资料。因为动脉粥洋硬化是慢性过程,所以妊期停用降脂药"}, {"probability": {"variance": 0.006369, "average": 0.969364, "min": 0.625168}, "location": {"width": 1153, "top": 893, "height": 52, "left": 196}, "words": "对原发性高胆固醇血症的长期治疗效果影响甚少,胆固醇及其生物合成途径的其他产物是胎"}, {"probability": {"variance": 0.014098, "average": 0.953453, "min": 0.376362}, "location": {"width": 1155, "top": 941, "height": 47, "left": 196}, "words": "儿发育的必成份,包括类固醇和细胞膜的合成因为HAG-CoA还原酶抑制剂如辛伐他汀能"}, {"probability": {"variance": 0.009563, "average": 0.969341, "min": 0.497112}, "location": {"width": 1132, "top": 984, "height": 41, "left": 198}, "words": "降低胆固醇及其生物合成途径的其他产物的合成,所以孕妇禁用辛伐他汀。在育龄妇女中"}, {"probability": {"variance": 0.002364, "average": 0.978016, "min": 0.769678}, "location": {"width": 1151, "top": 1023, "height": 47, "left": 198}, "words": "辛伐他汀只能用于那些怀孕可能性很小的妇女。若妇女在服药过程中怀孕,则应停用产伐他"}, {"probability": {"variance": 0.016558, "average": 0.946138, "min": 0.604825}, "location": {"width": 447, "top": 1071, "height": 45, "left": 196}, "words": "汀并被告知对胎儿可能造成的损伤"}, {"probability": {"variance": 0.010815, "average": 0.968183, "min": 0.459657}, "location": {"width": 1094, "top": 1107, "height": 47, "left": 255}, "words": "目前还不了解辛伐他汀及其代谢产物是否经人乳分泌,因为许多药物经人乳分泌,且可"}, {"probability": {"variance": 0.006088, "average": 0.972986, "min": 0.619345}, "location": {"width": 984, "top": 1151, "height": 47, "left": 201}, "words": "能引起严重六良反应,所以服用辛伐他汀的妇女不宜哺乳(请参阅【禁忌】)"}, {"probability": {"variance": 1.3e-05, "average": 0.994465, "min": 0.9905}, "location": {"width": 164, "top": 1201, "height": 34, "left": 207}, "words": "【儿童用药"}, {"probability": {"variance": 0.011288, "average": 0.967887, "min": 0.399234}, "location": {"width": 909, "top": 1237, "height": 41, "left": 258}, "words": "儿童用药的安全性和有效性尚未确定辛伐他打目前不推荐给儿童服用"}, {"probability": {"variance": 0.000966, "average": 0.978226, "min": 0.916936}, "location": {"width": 166, "top": 1285, "height": 36, "left": 207}, "words": "【老年用药"}, {"probability": {"variance": 0.01203, "average": 0.958018, "min": 0.418242}, "location": {"width": 1094, "top": 1322, "height": 43, "left": 258}, "words": "在老年患者大于65岁),应用辛伐他汀的临床对照研究中,其降低总胆固醇和低密度"}, {"probability": {"variance": 0.002368, "average": 0.984941, "min": 0.692845}, "location": {"width": 1148, "top": 1363, "height": 41, "left": 201}, "words": "脂蛋白(LDL)胆固醇的效果与其他人群的结果相似,不良反应和实验室检查异常的发生率也"}, {"probability": {"variance": 0, "average": 0.999755, "min": 0.999492}, "location": {"width": 148, "top": 1413, "height": 34, "left": 203}, "words": "无明显增多"}, {"probability": {"variance": 0, "average": 0.784747, "min": 0.784747}, "location": {"width": 75, "top": 1420, "height": 29, "left": 1215}, "words": "合"}, {"probability": {"variance": 0.001023, "average": 0.980767, "min": 0.903634}, "location": {"width": 223, "top": 1454, "height": 34, "left": 210}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.014742, "average": 0.953844, "min": 0.460397}, "location": {"width": 1096, "top": 1489, "height": 43, "left": 258}, "words": "吉非贝齐和其它贝特类药物,降脂剂量(知1g/天)的烟酸(尼克酸):这些药物与辛"}, {"probability": {"variance": 0.002093, "average": 0.983569, "min": 0.773515}, "location": {"width": 1148, "top": 1532, "height": 43, "left": 203}, "words": "伐他汀合用时发生肌病的危险性增加,可能是因为这些药物单独使用时均能引起肌病发生"}, {"probability": {"variance": 0.000615, "average": 0.986896, "min": 0.900963}, "location": {"width": 1123, "top": 1573, "height": 45, "left": 216}, "words": "请参阅【意事项】肌肉作用)。尚无证据显示这些药物对辛伐他汀的药代动力学有影响"}, {"probability": {"variance": 0.000274, "average": 0.992167, "min": 0.93879}, "location": {"width": 280, "top": 1621, "height": 34, "left": 262}, "words": "与CYP3A4的相互作用"}, {"probability": {"variance": 0.00112, "average": 0.983075, "min": 0.84793}, "location": {"width": 1091, "top": 1660, "height": 38, "left": 260}, "words": "辛伐他汀无CYP3A4抑制活性,因此,推测它不影响其它经CYP3A4代谢的药物的血浆水"}, {"probability": {"variance": 0.003339, "average": 0.976736, "min": 0.69065}, "location": {"width": 1148, "top": 1701, "height": 41, "left": 203}, "words": "平。然而,辛伐汀本身是CYP3A4的底物。在辛伐他汀治疗期内,CYP3A的强抑制剂可能"}, {"probability": {"variance": 0.007115, "average": 0.969222, "min": 0.521278}, "location": {"width": 1148, "top": 1745, "height": 41, "left": 203}, "words": "通过增加血浆HMKi-CoA还原酶抑制活性水平而增加肌病发生的危险性这些强抑制剂包括环"}, {"probability": {"variance": 0.023013, "average": 0.937429, "min": 0.365364}, "location": {"width": 1148, "top": 1786, "height": 43, "left": 203}, "words": "孢菌素、米地尔、伊曲康唑、酮康唑、红霉素、克拉霉素、HIV蛋白酶排制剂及法唑酮"}, {"probability": {"variance": 0.015164, "average": 0.951612, "min": 0.527612}, "location": {"width": 420, "top": 1834, "height": 36, "left": 216}, "words": "(请参阅【注意事项】肌肉作用"}, {"probability": {"variance": 0.022318, "average": 0.948324, "min": 0.379598}, "location": {"width": 1089, "top": 1872, "height": 36, "left": 264}, "words": "葡萄柚十中含有一种或多种抑制CYP3A4的成份,并能增加经C3A4代谢的药物的血浆"}, {"probability": {"variance": 0.01674, "average": 0.949855, "min": 0.411407}, "location": {"width": 1130, "top": 1911, "height": 45, "left": 201}, "words": "水平。常规用量(每日一杯250ml)所产生的效果很小(通过测量浓度时间曲线下面积"}, {"probability": {"variance": 0.006657, "average": 0.960906, "min": 0.584376}, "location": {"width": 1146, "top": 1955, "height": 38, "left": 207}, "words": "血浆HG-CcA还原酶抑制活性增加13%),且无临床意义。然而,如在辛伐他汀治疗期内大"}, {"probability": {"variance": 0.018077, "average": 0.933215, "min": 0.362809}, "location": {"width": 1151, "top": 1998, "height": 36, "left": 205}, "words": "量饮用(每超过1升),则明显增加血浆HMG-CoA还原酶抑制活性水平,应加以避免(请"}, {"probability": {"variance": 8.2e-05, "average": 0.994863, "min": 0.966414}, "location": {"width": 372, "top": 2041, "height": 38, "left": 205}, "words": "参阅【注意事项】肌肉作用)"}], "language": 3}